Table 3.
Quantification of GS1 and GS2 C. concisus in saliva samples from patients with IBD and healthy controls.
| Samples' No. | Status | Average copy number for GS1 | Average copy number for GS2 | Ratio (GS2/GS1) | t-test (P-value) |
|---|---|---|---|---|---|
| 1 | CD | 1.78E+06 | 8.09E+07 | 45.47 | 0.0000025 |
| 2 | CD | 4.53E+06 | 1.73E+07 | 3.83 | 0.0002848 |
| 3 | CD | 1.05E+07 | 8.35E+07 | 7.92 | 0.0000034 |
| 4 | CD | 8.61E+04 | 7.15E+06 | 83.06 | 0.0087320 |
| 5 | CD | 7.73E+05 | 3.11E+06 | 4.03 | 0.0001298 |
| 6 | CD | 3.71E+05 | 1.16E+07 | 31.25 | 0.0001030 |
| 7 | CD | 1.19E+07 | 4.89E+07 | 4.11 | 0.0022292 |
| 8 | CD | 1.31E+05 | 8.21E+05 | 6.28 | 0.0154187 |
| 9 | CD | 1.37E+06 | 3.91E+05 | 0.28 | 0.0009157 |
| 10 | CD | 8.04E+06 | 2.15E+07 | 2.67 | 0.0044400 |
| 11 | UC | 2.13E+05 | 1.68E+06 | 7.93 | 0.0000113 |
| 12 | UC | 3.75E+06 | 8.26E+06 | 2.20 | 0.0002831 |
| 13 | UC | 4.34E+05 | 5.27E+06 | 12.15 | 0.0016518 |
| 14 | HC | 1.98E+05 | 1.24E+07 | 62.81 | 0.0000027 |
| 15 | HC | 1.03E+06 | 8.63E+05 | 0.83 | 0.0899524 |
| 16 | HC | 1.45E+05 | 2.10E+06 | 14.43 | 0.0000639 |
| 17 | HC | 4.06E+05 | 2.51E+06 | 6.17 | 0.0006932 |
| 18 | HC | 5.53E+04 | 6.09E+05 | 11.02 | 0.0037420 |
| 19 | HC | 6.85E+05 | 4.31E+06 | 6.29 | 0.0000032 |
| 20 | HC | 1.10E+05 | 2.50E+06 | 22.65 | 0.0003467 |
| 21 | HC | 7.34E+05 | 1.83E+07 | 24.91 | 0.0000337 |
| 22 | HC | 1.59E+05 | 4.79E+06 | 30.20 | 0.0000597 |
| 23 | HC | 2.88E+04 | 2.90E+06 | 100.84 | 0.0007940 |
| 24 | HC | 9.80E+04 | 6.26E+05 | 6.38 | 0.0006584 |
| 25 | HC | 1.47E+05 | 5.92E+05 | 4.03 | 0.0009846 |
| 26 | HC | 1.84E+06 | 5.14E+06 | 2.79 | 0.0003896 |
| 27 | HC | 1.04E+06 | 1.35E+07 | 12.89 | 0.0000683 |
Ratio: the average GS2 copy numbers divided by the average GS1 copy numbers of the same sample. All saliva samples carried more copy numbers of GS2 than GS1 C. concisus, except for samples 9 and 15. CD, Crohn's Disease; UC, ulcerative colitis; HC, healthy control.